Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwCLL 2019

MRD

View all
2:43
The value of MRD assessment in CLL
Arnon Kater • 20 Sep 2019
1:44
Is MRD ready for clinical practice?
Lydia Scarfò • 31 Oct 2019

Panel Discussions

View all
14:54
Assessing the role of CAR-T in CLL
David Maloney et al. • 21 Sep 2019
13:34
CLL biology and patient stratification
Arnon Kater et al. • 20 Sep 2019

Real World Data

View all
2:27
Real-world evidence of venetoclax vs ibrutinib vs idelalisib
Toby Eyre • 21 Sep 2019
4:12
Geographic diversity and management of CLL in South American patients
Carlos Sérgio Chiattone • 22 Sep 2019

Disease Biology

View all
2:03
Genome sequencing as a prognostic tool
Richard Rosenquist • 22 Sep 2019
3:11
Overcoming resistance to BTK inhibition in CLL
Jennifer Woyach • 22 Sep 2019
The content of VJHemOnc is intended for healthcare professionals